Clinical Investigation To Evaluate Cerviron Ovules® in Symptomatic Vaginitis

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

September 9, 2021

Study Completion Date

September 9, 2021

Conditions
Vaginitis and Vulvovaginitis
Interventions
DEVICE

Cerviron

Cerviron ovules ® is a class IIb medical device indicated as adjuvant in the treatment of acute and chronic vulvovaginitis of mechanical etiology, caused by changes of vaginal pH and changes of the vaginal flora. It is also used in cervical lesions of mechanical origin as it favors the healing and re-epithelialization processes and reduces the proliferation of endogenous pathogens.

Trial Locations (2)

Unknown

"Spitalul Clinic Județean de Urgență Pius Brinzeu", Timișoara

"Institutul National pentru Sanatatea Mamei si Copilului (INSMC) Alessandrescu - Rusescu", Bucharest

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

MDX Research

NETWORK

lead

Perfect Care Distribution

INDUSTRY

NCT04735705 - Clinical Investigation To Evaluate Cerviron Ovules® in Symptomatic Vaginitis | Biotech Hunter | Biotech Hunter